130 related articles for article (PubMed ID: 16611329)
21. Tregs and Mixed Chimerism as Approaches for Tolerance Induction in Islet Transplantation.
Pathak S; Meyer EH
Front Immunol; 2020; 11():612737. PubMed ID: 33658995
[TBL] [Abstract][Full Text] [Related]
22. Costimulation blockade of both inducible costimulator and CD40 ligand induces dominant tolerance to islet allografts and prevents spontaneous autoimmune diabetes in the NOD mouse.
Nanji SA; Hancock WW; Luo B; Schur CD; Pawlick RL; Zhu LF; Anderson CC; Shapiro AM
Diabetes; 2006 Jan; 55(1):27-33. PubMed ID: 16380473
[TBL] [Abstract][Full Text] [Related]
23. Nonlethal conditioning for the induction of allogeneic chimerism and tolerance to islet allografts.
Li H; Inverardi L; Molano RD; Pileggi A; Ricordi C
Transplantation; 2003 Apr; 75(7):966-70. PubMed ID: 12698081
[TBL] [Abstract][Full Text] [Related]
24. Islet allograft rejection in nonobese diabetic mice involves the common gamma-chain and CD28/CD154-dependent and -independent mechanisms.
Demirci G; Strom TB; Li XC
J Immunol; 2003 Oct; 171(7):3878-85. PubMed ID: 14500690
[TBL] [Abstract][Full Text] [Related]
25. Long-term islet graft survival in NOD mice by abrogation of recurrent autoimmunity.
Shi Q; Wang D; Hadley GA; Bingaman AW; Bartlett ST; Farber DL
Diabetes; 2004 Sep; 53(9):2338-45. PubMed ID: 15331543
[TBL] [Abstract][Full Text] [Related]
26. Addition of Anti-CD40 Monoclonal Antibody to Nonmyeloablative Conditioning With Belatacept Abrogated Allograft Tolerance Despite Induction of Mixed Chimerism.
Oura T; Hotta K; Rosales I; Dehnadi A; Kawai K; Lee H; Benedict Cosimi A; Kawai T
Transplantation; 2019 Jan; 103(1):168-176. PubMed ID: 30113996
[TBL] [Abstract][Full Text] [Related]
27. Induction of stable chimerism and transplantation tolerance to rat islet and heart allografts by ultraviolet-B modulation of bone marrow cells.
Jin MX; Engelstad K; Oluwole SF
Transplantation; 1992 Jul; 54(1):113-8. PubMed ID: 1385914
[TBL] [Abstract][Full Text] [Related]
28. Endogenous expansion of regulatory T cells leads to long-term islet graft survival in diabetic NOD mice.
Shi Q; Lees JR; Scott DW; Farber DL; Bartlett ST
Am J Transplant; 2012 May; 12(5):1124-32. PubMed ID: 22299822
[TBL] [Abstract][Full Text] [Related]
29. Robust tolerance to fully allogeneic islet transplants achieved by chimerism with minimal conditioning.
Luo B; Nanji SA; Schur CD; Pawlick RL; Anderson CC; Shapiro AM
Transplantation; 2005 Aug; 80(3):370-7. PubMed ID: 16082333
[TBL] [Abstract][Full Text] [Related]
30. Combination therapy of an iNKT cell ligand and CD40-CD154 blockade establishes islet allograft acceptance in nonmyeloablative bone marrow transplant recipients.
Kanzawa T; Hirai T; Fukuda H; Katsumata H; Ishii R; Ikemiyagi M; Ishii Y; Saiga K; Okumi M; Tanabe K
Acta Diabetol; 2019 May; 56(5):541-550. PubMed ID: 30758788
[TBL] [Abstract][Full Text] [Related]
31. Resistance of spontaneously diabetic Ins2(akita) mice to allograft tolerance induced by anti-CD154 therapy.
Bishop NH; Beard KS; Gill RG
Transplant Proc; 2014; 46(6):2007-9. PubMed ID: 25131095
[TBL] [Abstract][Full Text] [Related]
32. Effect of STZ administration on islet isograft and allograft survival in NOD mice.
Takayama Y; Ichikawa T; Maki T
Diabetes; 1993 Feb; 42(2):324-9. PubMed ID: 8425668
[TBL] [Abstract][Full Text] [Related]
33. Mixed hematopoietic chimerism allows cure of autoimmune diabetes through allogeneic tolerance and reversal of autoimmunity.
Nikolic B; Takeuchi Y; Leykin I; Fudaba Y; Smith RN; Sykes M
Diabetes; 2004 Feb; 53(2):376-83. PubMed ID: 14747288
[TBL] [Abstract][Full Text] [Related]
34. Depleting anti-CD4 monoclonal antibody cures new-onset diabetes, prevents recurrent autoimmune diabetes, and delays allograft rejection in nonobese diabetic mice.
Makhlouf L; Grey ST; Dong V; Csizmadia E; Arvelo MB; Auchincloss H; Ferran C; Sayegh MH
Transplantation; 2004 Apr; 77(7):990-7. PubMed ID: 15087759
[TBL] [Abstract][Full Text] [Related]
35. Combined islet and hematopoietic stem cell allotransplantation: a clinical pilot trial to induce chimerism and graft tolerance.
Mineo D; Ricordi C; Xu X; Pileggi A; Garcia-Morales R; Khan A; Baidal DA; Han D; Monroy K; Miller J; Pugliese A; Froud T; Inverardi L; Kenyon NS; Alejandro R
Am J Transplant; 2008 Jun; 8(6):1262-74. PubMed ID: 18444924
[TBL] [Abstract][Full Text] [Related]
36. Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation.
Pan H; Zhao K; Wang L; Zheng Y; Zhang G; Mai H; Han Y; Yang L; Guo S
J Surg Res; 2010 May; 160(2):315-24. PubMed ID: 19524257
[TBL] [Abstract][Full Text] [Related]
37. Effect of liver transplantation on islet allografts: up-regulation of Fas ligand and apoptosis of T lymphocytes are associated with islet graft tolerance.
Wang XY; Sun J; Wang C; France M; Sheil AG
Transplantation; 2001 Jan; 71(1):102-11. PubMed ID: 11211174
[TBL] [Abstract][Full Text] [Related]
38. A more persistent tolerance to islet allografts through bone marrow transplantation in minimal nonmyeloablative conditioning therapy.
Lee BW; Lee JI; Oh SH; Ahn YR; Chae HY; Lee MS; Lee MK; Kim KW
Transplant Proc; 2005 Jun; 37(5):2266-9. PubMed ID: 15964395
[TBL] [Abstract][Full Text] [Related]
39. Nondepleting anti-CD4 and soluble interleukin-1 receptor prevent autoimmune destruction of syngeneic islet grafts in diabetic NOD mice.
Drage M; Zaccone P; Phillips JM; Nicoletti F; Dawson J; Andrew Bradley J; Cooke A
Transplantation; 2002 Sep; 74(5):611-9. PubMed ID: 12352875
[TBL] [Abstract][Full Text] [Related]
40. Low levels of allogeneic but not syngeneic hematopoietic chimerism reverse autoimmune insulitis in prediabetic NOD mice.
Kaminitz A; Mizrahi K; Yaniv I; Farkas DL; Stein J; Askenasy N
J Autoimmun; 2009 Sep; 33(2):83-91. PubMed ID: 19632089
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]